Kinetic and structural characterization of caspase-3 and caspase-8 inhibition by a novel class of irreversible inhibitors
Zhigang Wang(Tsinghua University), Alfredo G. Tomasselli(Pfizer (United States)), Melissa S. Harris(Pfizer (United States)), Robert L. Heinrikson(Wayne State University), Arthur J. Wittwer(Pfizer (United States)), Satwik Kamtekar(Pfizer (United States)), James R. Blinn(Pfizer (United States)), Douglas Boatman(Arena Pharmaceuticals (United States)), Nathan A. Brooks(Eli Lilly (United States)), B.C. Finzel(University of Alabama at Birmingham), Ján Urban(University of Cologne), Michael Kahn(University of Southern California), William Watt(Pfizer (United States)), Michael McMillan(University of Southern California)
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
May 25, 2010
Cited by 70
Related Papers
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.
|Journal of Biological Chemistry|1993|799
Structural basis of substrate discrimination and integrin binding by autotaxin
|Nature Structural & Molecular Biology|2011|280
Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
|The Journal of Urology|2019|190
100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19
|Nature Reviews Urology|2021|154
Human β-Secretase (BACE) and BACE Inhibitors
|Journal of Medicinal Chemistry|2003|146